The Top 20 Most Innovative Chinese Universities

Posted by LexisNexis PatentSight team on Nov 12, 2018 1:15:01 PM

 跳转到简体中文 (jump to Simplified Chinese):

中国高校创新力前20强

 

Today, LexisNexis published a ranking of China’s top 20 most innovative universities based on their patent assets. Analysts at LexisNexis have identified these top universities as sorted by the Patent Asset Index™.

 

Read More

Tags: Patent Asset Index, Patent Valuation, Innovation, Science, Technology


Roche up, Pfizer out - The Patent Asset Index™ for Alzheimer’s and Parkinson’s patents

Posted by Benjamin Hann on Oct 16, 2018 8:33:56 AM

 

As of today effective drugs for Alzheimer’s and Parkinson’s diseases are missing. In fact, Pharma giant Pfizer recently announced that they’re ending their research in this field. Which from an innovation analytics point of view does not come as a complete surprise.

Read More

Tags: Patent Asset Index, Patent Analysis, Patent Valuation


PatentSight is now part of LexisNexis® IP

Posted by Nils Omland on May 16, 2018 2:32:17 PM

You may have seen our recent press release but I wanted to personally express my excitement over the recent acquisition by LexisNexis® IP. We anticipate that as a result of this acquisition, we will be able to make significant enhancements to our product.

With added content, financial resources, and a broader customer base we will significantly accelerate our development. In particular, the advent of powerful self-learning algorithms often described as “artificial intelligence” is a great opportunity to reach the next breakthrough in patent analytics. We are thrilled to leverage our competence in high quality data and reliable science-based algorithms to continue leading the field with advanced tools that offer unique and reliable business insights.

Rest assured, many things you value about PatentSight will not change. PatentSight will continue under the leadership of myself and my team in the same offices in Bonn, Germany. All PatentSight employees will be retained and your current points of contact will not change. Our much-praised Consulting & Support Team will continue to serve you directly. The name of the product will change slightly to LexisNexis PatentSight.

We look forward to our continued relationship. Please contact me, Björn Ulmer or your main contact in the business development team if you have any additional questions.

Read More

Tags: Mergers and Acquisitions, Patent Valuation, Science, Technology, IP Data Quality, Patent Analysis, Innovation, Patent Asset Index